tv3326 has been researched along with clioquinol in 1 studies
| Studies (tv3326) | Trials (tv3326) | Recent Studies (post-2010) (tv3326) | Studies (clioquinol) | Trials (clioquinol) | Recent Studies (post-2010) (clioquinol) |
|---|---|---|---|---|---|
| 15 | 0 | 11 | 1,060 | 59 | 218 |
| Protein | Taxonomy | tv3326 (IC50) | clioquinol (IC50) |
|---|---|---|---|
| kappa-type opioid receptor isoform 1 | Homo sapiens (human) | 5.79 | |
| Amyloid-beta precursor protein | Homo sapiens (human) | 9.8 | |
| Spike glycoprotein | Severe acute respiratory syndrome coronavirus 2 | 5.6 | |
| Catechol O-methyltransferase | Rattus norvegicus (Norway rat) | 4.7863 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, Y; Huang, L; Li, X; Lu, C; Luo, HB; Luo, Z; Yan, J; Yan, M | 1 |
1 other study(ies) available for tv3326 and clioquinol
| Article | Year |
|---|---|
Design, synthesis, and evaluation of multitarget-directed resveratrol derivatives for the treatment of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Antioxidants; Blood-Brain Barrier; Cholinesterase Inhibitors; Clioquinol; Drug Design; Humans; Mice; Monoamine Oxidase Inhibitors; Peptide Fragments; Resveratrol; Stilbenes | 2013 |